ARTELO BIOSCIENCES, INC. Quarterly Debt-to-equity in % from Q2 2016 to Q2 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Artelo Biosciences, Inc. quarterly Debt-to-equity history and growth rate from Q2 2016 to Q2 2024.
Artelo Biosciences, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 9.4 %, a 137% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2024	9.4	+5.43	+137%	Jun 30, 2024
Q1 2024	6.98	+3.43	+96.6%	Mar 31, 2024
Q4 2023	6.08	+2.75	+82.7%	Dec 31, 2023
Q3 2023	5	+1.87	+59.8%	Sep 30, 2023
Q2 2023	3.96	+0.38	+10.6%	Jun 30, 2023
Q1 2023	3.55			Mar 31, 2023
Q4 2022	3.33			Dec 31, 2022
Q3 2022	3.13			Sep 30, 2022
Q2 2022	3.59			Jun 30, 2022
Q2 2017	-262	-1.24K	-127%	May 31, 2017
Q1 2017	-149			Feb 28, 2017
Q4 2016	-142			Nov 30, 2016
Q3 2016	-155			Aug 31, 2016
Q2 2016	977			May 31, 2016

* An asterisk sign (*) next to the value indicates that the value is likely invalid.